New inhaled levodopa formulation being tested for PD


REPORT FROM THE AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING, PHILADELPHIA PA, APRIL 26-MAY 3, 2014 – A new phase II study reports that a novel dry-powder formulation of inhaled levodopa, CVT-301, may be useful for rapid improvement in motor function during Off periods (Freed et al. AAN 2014; abstract S7.007).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page